Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SILO
#3953
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+5.71%
Aylık değişim
-2.63%
6 aylık değişim
-42.19%
Yıllık değişim
-72.59%
Önceki kapanış
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Hacim
3
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
SILO
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.7 M
1.97 M
3.16 M
2.84 M
4.48 M
—
Valuation ratios
Enterprise value
—
—
-1.67 M
799.02 K
85.37 K
9.06 M
Price to earnings ratio
—
—
-1.8
-1.27
-0.75
-3.14
Price to sales ratio
—
—
81.8
64.93
45.43
185.68
Price to cash flow ratio
—
—
-2
-1.45
-0.85
-2.99
Price to book ratio
—
—
0.68
0.76
0.65
1.14
Enterprise value to EBITDA ratio
—
—
—
—
-0.02
—
Profitability ratios
Return on assets %
2.13
0.37
-0.34
-0.48
-0.59
-0.76
Return on equity %
2.37
0.43
-0.38
-0.6
-0.87
-1.07
Return on invested capital %
4 129.66
-5 369.36
-4 045.39
-4 981.19
-7 388.04
-5 936.51
Gross margin %
-330.38
1
77.29
91.9
91.9
260.94
Operating margin %
6 287.34
-41.21
-4 231.34
-5 347.41
-6 526.44
-29.44 K
EBITDA margin %
-4 912.8
—
—
—
-6 517.86
-29.38 K
Net margin %
7 422.52
58.62
-4 558.98
-5 132.57
-6 092.59
-28.16 K
Liquidity ratios
Quick ratio
9.83
21.17
—
—
—
—
Current ratio
10.07
21.23
26.52
9.9
4.29
23.8
Inventory turnover
1.86
0
—
—
—
—
Asset turnover
0.04
1.12
0.01
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0.04
0.01
—
—
Long term debt to total equity ratio
0
0
0.04
0.01
—
—
Per share metrics
Operating cash flow per share
—
-1.19
-1.53
-1.05
-1.04
-0.92
EBIT per share
—
2
-1.58
-1.25
-1.28
-1.06
EBITDA per share
—
—
—
—
-1.28
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.13
4.98
2.49
1.92
4.76
Net current asset value per share
—
5.42
5.07
2.49
1.93
4.86
Tangible book value per share
—
4.72
4.53
2.01
1.3
3.4
Working capital per share
—
5.17
4.88
2.24
1.48
3.9
Book value per share
—
4.72
4.53
2.01
1.37
3.58
Haberler
Silo Pharma hisseleri 1 milyon dolarlık geri alımla yükseldi
Silo Pharma stock surges on $1M share buyback program
Silo Pharma 1 milyon dolarlık geri alım programı onayladı
Silo Pharma authorizes $1 million stock buyback program
Japonya, Silo Pharma’nın PTSD tedavisine patent verdi
Japan grants patent for Silo Pharma’s PTSD treatment
Silo Pharma, SPC-15 burun spreyi klinik denemeleri için Allucent ile niyet mektubu imzaladı
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
Silo Pharma CEO’su Weisblum şirkette 735 dolarlık hisse satın aldı
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
Silo Pharma selects Alphaledger T12 fund for blockchain asset investments